These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 233541)

  • 41. Evaluation of the in vivo efficacy of a new vaginal contraceptive agent in stumptailed macaques.
    Zaneveld LJ; Burns JW; Goodpasture JC; Vickery BH
    Fertil Steril; 1984 Mar; 41(3):455-9. PubMed ID: 6698237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Collaboration with academia in the development of vaginal microbicides.
    Upmalis DH
    Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S55-8. PubMed ID: 10661741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative analysis of nonoxynol-9 in blood.
    Yang JT; Zhao ZW
    Contraception; 1991 Feb; 43(2):161-6. PubMed ID: 1645636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the rheological properties of Advantage-S and Replens.
    Owen DH; Peters JJ; Katz DF
    Contraception; 2001 Dec; 64(6):393-6. PubMed ID: 11834239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of two vaginal tablets: FHI findings mixed.
    Netw Res Triangle Park N C; 1983 Sep; 4(4):5. PubMed ID: 12279631
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toxic shock syndrome and the vaginal contraceptive sponge.
    Faich G; Pearson K; Fleming D; Sobel S; Anello C
    JAMA; 1986 Jan; 255(2):216-8. PubMed ID: 3001376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaginal contraception--an update.
    Edelman DA; Thompson S
    Contracept Deliv Syst; 1982 Apr; 3(2):75-81. PubMed ID: 12338173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute urinary retention secondary to urethral inflammation from a vaginal contraceptive suppository in a 17-year-old boy.
    Saborio DV; Kennedy WA; Hoke GP
    Urol Int; 1997; 58(2):128-30. PubMed ID: 9096278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the spermicidal activity and acute toxicity of nonoxynol-9 and agent 741 [alkylphenoxy polyethoxy ethanol(10)].
    Diao XH; Chen Q; Waller DP; Kaminski J; Zaneveld LJ
    Contraception; 1986 Jan; 33(1):1-5. PubMed ID: 3007021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial.
    Barnhart KT; Rosenberg MJ; MacKay HT; Blithe DL; Higgins J; Walsh T; Wan L; Thomas M; Creinin MD; Westhoff C; Schlaff W; Archer DF; Ayers C; Kaunitz A; Das S; Moench TR
    Obstet Gynecol; 2007 Sep; 110(3):577-86. PubMed ID: 17766603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New spermicide: FHI developing propranolol.
    Netw Res Triangle Park N C; 1986; 7(2):2-3. PubMed ID: 12340619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of virus dose and nonoxynol-9 on the genital transmission of SIV in rhesus macaques.
    Miller CJ; Alexander NJ; Sutjipto S; Joye SM; Hendrickx AG; Jennings M; Marx PA
    J Med Primatol; 1990; 19(3-4):401-9. PubMed ID: 2172544
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers.
    Marais D; Carrara H; Kay P; Ramjee G; Allan B; Williamson AL
    Virus Res; 2006 Nov; 121(2):220-2. PubMed ID: 16860426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Topical contraceptives].
    Alipov VI; Korkhov VV
    Akush Ginekol (Mosk); 1982 Feb; (2):5-7. PubMed ID: 7044166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multipurpose spermicides.
    Lancet; 1992 Jul; 340(8813):211-3. PubMed ID: 1353141
    [No Abstract]   [Full Text] [Related]  

  • 56. Spermicide acceptability among patients at a sexually transmitted disease clinic in Zambia.
    Hira SK; Spruyt AB; Feldblum PJ; Sunkutu MR; Glover LH; Steiner MJ
    Am J Public Health; 1995 Aug; 85(8 Pt 1):1098-103. PubMed ID: 7625503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study of the intravaginal insert (IVI): acceptability, side effects, and post-coital spermicidal activity.
    Ahmad M; Asch RH
    Acta Eur Fertil; 1984; 15(5):369-76. PubMed ID: 6099026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sensitivity to vaginal jellies: a note on the therapeutic index of spermicides.
    HOLZAEPFEL JH; WARNER JS; HOWARD JA
    J Am Pharm Assoc Am Pharm Assoc; 1959 Aug; 48(8):486-7. PubMed ID: 13672850
    [No Abstract]   [Full Text] [Related]  

  • 59. Mucosal integrity and inflammatory markers in the female lower genital tract as potential screening tools for vaginal microbicides.
    Su HI; Schreiber CA; Fay C; Parry S; Elovitz MA; Zhang J; Shaunik A; Barnhart K
    Contraception; 2011 Nov; 84(5):525-32. PubMed ID: 22018129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Postcoital testing after the use of a bio-adhesive acid buffering gel (ACIDFORM) and a 2% nonoxynol-9 product.
    Amaral E; Perdigão A; Souza MH; Mauck C; Waller D; Zaneveld L; Faúndes A
    Contraception; 2004 Dec; 70(6):492-7. PubMed ID: 15541412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.